Neumora Therapeutics, Inc. - NMRA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$140M

QoQ value delta ($000)

-$1.248M (-0.88%)

Implied price effect (QoQ)

-12.54%

Total shares

82,106,462

QoQ shares delta

+9,658,935 (+13.33%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 114 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Siren, L.L.C.	14,446	8,497,822	0.29%
BlackRock, Inc.	13,246	7,791,869	0.0%
SOFTBANK GROUP CORP.	10,353	6,090,301	0.06%
TUDOR INVESTMENT CORP ET AL	8,825	5,191,347	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	7,938	4,669,585	0.0%
MIC Capital Management UK LLP	7,583	4,460,700	1.92%
FMR LLC	5,948	3,498,869	0.0%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST	5,625	3,309,123	0.06%
GEODE CAPITAL MANAGEMENT, LLC	4,433	2,607,289	0.0%
ICONIQ Capital, LLC	4,350	2,559,090	0.13%
TWO SIGMA INVESTMENTS, LP	3,816	2,244,829	0.0%
ORBIMED ADVISORS LLC	3,637	2,139,882	0.07%
Lunate Capital Ltd	3,611	2,124,143	1.84%
Boxer Capital Management, LLC	3,400	2,000,000	0.26%
JOHNSON & JOHNSON	3,144	1,849,445	0.39%
STATE STREET CORP	2,689	1,582,119	0.0%
Caption Management, LLC	2,345	1,379,517	0.01%
Ikarian Capital, LLC	2,173	1,278,408	0.23%
RENAISSANCE TECHNOLOGIES LLC	2,145	1,262,304	0.0%
Affinity Asset Advisors, LLC	1,820	1,070,651	0.08%
CITADEL ADVISORS LLC	1,816	1,068,733	0.0%
MARSHALL WACE, LLP	1,537	904,458	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	1,521	894,791	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,400	823,583	0.0%
NORTHERN TRUST CORP	1,360	800,571	0.0%